Compared to Estimates, Medtronic (MDT) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for Medtronic (MDT) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Medtronic to split off its fast-growing diabetes business to unlock its value
The new diabetes company will be predominantly business-to-consumer, while Medtronic's model was more business-to-business.
Medtronic (MDT) Q4 Earnings and Revenues Beat Estimates
Medtronic (MDT) came out with quarterly earnings of $1.62 per share, beating the Zacks Consensus Estimate of $1.58 per share. This compares to earnings of $1.46 per share a year ago.
Medtronic to Separate Diabetes Business
The medical device maker has been working to turn around the division over the last few years.
Will Medtronic's Earnings Move The Stock?
Medtronic (NYSE:MDT) is scheduled to announce its earnings on Wednesday, May 21, 2025. Over the last five years, Medtronic's stock has shown a favorable one-day return following its earnings announcements in 53% of instances.
What Analyst Projections for Key Metrics Reveal About Medtronic (MDT) Q4 Earnings
Get a deeper insight into the potential performance of Medtronic (MDT) for the quarter ended April 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Should You Continue to Hold Medtronic Stock in Your Portfolio Now?
Investors stay optimistic about MDT due to its strength in the Cardiovascular portfolio.
Medtronic (MDT) Stock Declines While Market Improves: Some Information for Investors
Medtronic (MDT) closed the most recent trading day at $84.25, moving -1.01% from the previous trading session.
Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing
In the closing of the recent trading day, Medtronic (MDT) stood at $83.62, denoting a +0.55% change from the preceding trading day.
Is Medtronic Stock a Buy Pre-Q4 Earnings? Key Metrics to Watch
Despite challenges, Medtronic demonstrates the resilience of its underlying business fundamentals, delivering consistent mid-single-digit organic revenue growth.
This Magnificent High-Yield Dividend Stock Just Became an Even Better Buy
Medical device specialist Medtronic (MDT 1.38%) has not performed well over the past five years; the stock has significantly lagged broader equities. One of the issues it's encountered is slow revenue growth.
Medtronic (MDT) Surpasses Market Returns: Some Facts Worth Knowing
Medtronic (MDT) closed the most recent trading day at $84.85, moving +1.54% from the previous trading session.
